Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Sell

Analyst Rating

Neutral

Simple Moving Average

Strong Buy

Exponential Moving Average

Buy

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Buy

Wall Street Data Solutions Rating

Neutral

B

Rigel Pharmaceuticals Inc. (New) (RIGL)

Pharmaceutical Preparations

https://www.rigel.com

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's lead drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility to develop and market the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.

611 GATEWAY BOULEVARD, SUITE 900
SOUTH SAN FRANCISCO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

11/29/2000

Market Cap

214,307,100

Shares Outstanding

174,370,000

Weighted SO

174,369,503

Total Employees

N/A

Upcoming Earnings

08/06/2024

Similar Tickers

FBIO --.--%

RVPH --.--%

CTIC --.--%

OCUP --.--%

NBRV --.--%

EIGR --.--%

PIRS --.--%

CDTX --.--%

XFOR --.--%

Beta

0.9580

Last Div

0.0000

Range

7.1-17.3

Chg

-0.2900

Avg Vol

186888

Mkt Cap

214307100

Exch

NASDAQ

Country

US

Phone

650 624 1100

DCF Diff

23.1831

DCF

-10.7131

Div Yield

0.0000

P/S

1.6447

EV Multiple

-39.3056

P/FV

-7.1454

Div Yield %

0.0000

P/E

-15.0187

PEG

-0.6107

Payout

0.0000

Current Ratio

1.6151

Quick Ratio

1.4402

Cash Ratio

0.6147

DSO

80.9661

DIO

378.6183

Op Cycle

459.5844

DPO

226.2336

CCC

233.3508

Gross Margin

0.9241

Op Margin

-0.0692

Pretax Margin

-0.1092

Net Margin

-0.1092

Eff Tax Rate

-0.1199

ROA

-0.1108

ROE

0.4664

ROCE

-0.1293

NI/EBT

1.0000

EBT/EBIT

1.5782

EBIT/Rev

-0.0692

Debt Ratio

0.4698

D/E

-2.0168

LT Debt/Cap

2.0046

Total Debt/Cap

1.9835

Int Coverage

-2.4700

CF/Debt

-0.2040

Equity Multi

-4.2926

Rec Turnover

4.5081

Pay Turnover

1.6134

Inv Turnover

0.9640

FA Turnover

193.0385

Asset Turnover

1.0147

OCF/Share

-0.7015

FCF/Share

-0.7295

Cash/Share

2.7980

OCF/Sales

-0.0945

FCF/OCF

1.0400

CF Coverage

-0.2040

ST Coverage

-19.2645

CapEx Coverage

-25.0203

Div&CapEx Cov

-25.0203

P/BV

-7.1454

P/B

-7.1454

P/S

1.6447

P/E

-15.0187

P/FCF

-16.7401

P/OCF

-17.3637

P/CF

-17.3637

PEG

-0.6107

P/S

1.6447

EV Multiple

-39.3056

P/FV

-7.1454

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation